APRI (Aprinoia Therapeutics) Effective Interest Rate on Debt %: 29.78% (As of Dec. 2023)


What is Aprinoia Therapeutics Effective Interest Rate on Debt %?

Aprinoia Therapeutics APRI Effective Interest Rate on Debt % is 29.78% as of Dec. 2023.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Aprinoia Therapeutics's annualized positive value of Interest Expense for the quarter that ended in Dec. 2023 was $5.15 Mil. Aprinoia Therapeutics's average total debt for the quarter that ended in Dec. 2023 was $17.29 Mil. Therefore, Aprinoia Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 was 29.78%.


Aprinoia Therapeutics  (NAS:APRI) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Aprinoia Therapeutics Effective Interest Rate on Debt % Related Terms


Aprinoia Therapeutics Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for Aprinoia Therapeutics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Effective Interest Rate on Debt % Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Effective Interest Rate on Debt %
3.23 3.50 37.05

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Effective Interest Rate on Debt % 0.00 2.33 3.99 31.56 29.78

APRI vs : Effective Interest Rate on Debt % Comparison

For the Biotechnology subindustry, Aprinoia Therapeutics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aprinoia Therapeutics Effective Interest Rate on Debt % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aprinoia Therapeutics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Aprinoia Therapeutics's Effective Interest Rate on Debt % falls into.



Aprinoia Therapeutics Effective Interest Rate on Debt % Calculation

Aprinoia Therapeutics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2022 )+Total Debt  (A: Dec. 2023 ))/ count )
=-1  *  -4.019/( (2.709+18.988)/ 2 )
=-1  *  -4.019/10.8485
=37.05 %

where

Total Debt  (A: Dec. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.042 + 2.667
=2.709

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.208 + 18.78
=18.988

Aprinoia Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Jun. 2023 )+Total Debt  (Q: Dec. 2023 ))/ count )
=-1  *  -5.15/( (15.595+18.988)/ 2 )
=-1  *  -5.15/17.2915
=29.78 %

where

Total Debt  (Q: Jun. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.015 + 15.58
=15.595

Total Debt  (Q: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.208 + 18.78
=18.988

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Dec. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 29.78% mean?
Aprinoia Therapeutics (APRI) has a Effective Interest Rate on Debt % of 29.78% as of Dec. 2023. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' Effective Interest Rate on Debt % too high?
Aprinoia Therapeutics' current Effective Interest Rate on Debt % is 29.78%.
How does Aprinoia Therapeutics' Effective Interest Rate on Debt % compare to ?
Aprinoia Therapeutics' Effective Interest Rate on Debt % of 29.78% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Biotechnology company?
A good Effective Interest Rate on Debt % depends on the Biotechnology industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current Effective Interest Rate on Debt % is 29.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current Effective Interest Rate on Debt % of 29.78%. The current Effective Interest Rate on Debt % is 29.78%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current Effective Interest Rate on Debt % is 29.78% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.